Show simple item record

dc.contributor.authorYakhelef, N
dc.contributor.authorAudibert, M
dc.contributor.authorFerlazzo, G
dc.contributor.authorSitienei, J
dc.contributor.authorWanjala, S
dc.contributor.authorVaraine, F
dc.contributor.authorBonnet, M
dc.contributor.authorHuerga, H
dc.date.accessioned2020-02-22T23:41:17Z
dc.date.available2020-02-22T23:41:17Z
dc.date.issued2020-01-30
dc.date.submitted2020-02-06
dc.identifier.issn1932-6203
dc.identifier.pmid31999746
dc.identifier.doi10.1371/journal.pone.0227138
dc.identifier.urihttp://hdl.handle.net/10144/619602
dc.description.abstractBACKGROUND: Tuberculosis (TB) is the leading cause of death among HIV-positive patients. We assessed the cost-effectiveness of including lateral-flow urine lipoarabinomannan (LF-LAM) in TB diagnostic algorithms for severely ill or immunosuppressed HIV-positive patients with symptoms of TB in Kenya. METHODS: From a decision-analysis tree, ten diagnostic algorithms were elaborated and compared. All algorithms included clinical exam. The costs of each algorithm were calculated using a 'micro-costing' method. The efficacy was estimated through a prospective study that included severely ill or immunosuppressed (CD4<200cells/μL) HIV-positive adults with symptoms of TB. The cost-effectiveness analysis was performed using the disability-adjusted life year (DALY) averted as effectiveness outcome. A 4% discount rate was applied. RESULTS: The algorithm that added LF-LAM alone to the clinical exam lead to the least average cost per TB case detected (€47) and was the most cost-effective with a cost/DALY averted of €4.6. The algorithms including LF-LAM, microscopy and X-ray, and LF-LAM and Xpert in sputum, detected a high number of TB cases with a cost/DALY averted of €6.1 for each of them. In the comparisons of the algorithms two by two, using LF-LAM instead of microscopy (clinic&LAM vs clinic&microscopy) and using LF-LAM along with GeneXpert in sputum instead of GeneXpert in urine along with GeneXpert in sputum, (clinic&LAM&Xpert_sputum vs clinic&Xpert_sputum&Xpert_urine) led to the highest increase in the cost-effectiveness ratios (ICERs): €-7.2 and €-12.6 respectively. In these two comparisons, using LF-LAM increased the number of TB patients detected while reducing costs. Adding LF-LAM to smear microscopy alone or to smear microscopy and Xray led to the highest increase in the additional number of TB cases detected (31 and 25 respectively) with an incremental efficiency estimated at 134 and 344 DALYs respectively. The ICERs were €22.0 and €8.6 respectively. CONCLUSION: Including LF-LAM in TB diagnostic algorithms is cost-effective for severely ill or immunosuppressed HIV-positive patients.en_US
dc.language.isoenen_US
dc.publisherPublic Library of Scienceen_US
dc.rightsWith thanks to Public Library of Science.en_US
dc.titleCost-effectiveness of diagnostic algorithms including lateral-flow urine lipoarabinomannan for HIV-positive patients with symptoms of tuberculosisen_US
dc.identifier.journalPLoS ONEen_US
dc.source.journaltitlePloS one
refterms.dateFOA2020-02-22T23:41:18Z


Files in this item

Thumbnail
Name:
Yakhelef et al 2020 Cost-effec ...
Size:
1.343Mb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record